4
Changes in Ownership
Merck & Co., Inc. Filed Acc 0001127602-21-028165
EVP&Pres, Merck Animal Heallth sold 135,405 shares at $87.56 ($11,856,265)
- EVP&Pres, Merck Animal Heallth acquired 135,405 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
DeLuca Richard R. · EVP&Pres, Merck Animal Heallth
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2021-10-29 | Exercise or conversion : show line 1 in the form | +73,026 | 189,955.96 | D | ||
| 2021-10-29 | Exercise or conversion : show line 2 in the form | +62,379 | 252,334.96 | D | ||
| 2021-10-29 | Sale : show line 3 in the form | −135,405 | $87.56 | $11,856,265 | 116,929.96 | D |
| Open-market sales · 135,405 sh · avg $87.56 · $11,856,265 | ||||||
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2021-10-29 | Exercise or conversion : show line 4 in the form Stock Option (Right to Buy) | −73,026 | 0 | D |
| 2021-10-29 | Exercise or conversion : show line 5 in the form Stock Option (Right to Buy) | −62,379 | 0 | D |
Loading xslF345X03/form4.xml…